Volume 4 No. 3, July 2009

Comparison between the Effect of Dexmedetomidine, Ketamine or Sedation-Analgesia Holiday on Weaning From Mechanical Ventilation after Sedation-Based Analgesia with Midazolam And Fentanyl
Ghada Fouad El-Baradey(1) & Soad S. Abd El-all El-Gaby(2)                                                              

 Department of Anesthesiology &ICU, Faculty of Medicine, Tanta University(1) & Department of Anesthesiology &ICU, Faculty of medicine for girls AL-Azhar University(2), Egypt.
Tanta Med. Sc. J 2009; 4(3):46-59
Original article

 

Abstract provided by Publisher   
Background/Aim: Mechanically ventilated patients in the intensive care unit (ICU) routinely require sedative and analgesic medications to manage pain, agitation and anxiety. Continuous infusion of midazolam and opioid for long term had unpredictable effect as respiratory depression, ventilator dependance and were associated with increase in duration of mechanical ventilation, length of ICU and hospital stays. With start of weaning reduction in the dose of midazolam and opioid were associated with withdrawal symptoms as agitation, anxiety, hypertension, tachycardia, tachypnea and ventilator desynchrony. Both the cumulative effect and the withdrawal symptoms of these drugs hinder weaning and arose the need for different protocols, strategies or alternative drugs. The Aim of the study is to minimize the impact of long term infusion of midazolam & fentanyl and to suppress their withdrawal symptoms by comparing their substitution with start of weaning by different classes of drugs as ketamine or dexmedetomidine or by using different strategy as daily midazolam & fentanyl interruption (sedation-analgesia holiday) in order to choose the best method which help early weaning without complication. Patients & Methods: This study was carried out on 60 adult patients that expected to require mechanical ventilation for more than 48 hours after major surgeries. At end of surgery artificial ventilation continued in ICU with synchronized intermittent mandatory ventilation (SIMV) with pressure support (PS) mode. All patients received sedation with midazolam 0.1-0.5 mg/Kg/h intravenous (IV) & analgesia with fentanyl 0.25-0.5 μg/Kg/h IV infusion was adjusted hourly as required by the patients based on sedation–agitation scale (SAS) 3 or 4 and pain intensity score using behavioral pain scale (BPS) 1 or 2. Patients were randomly allocated into 4 groups: 1) Control group (group C): Patients received midazolam & fentanyl infusion till weaning &extubation. 2) Sedation-analgesia holiday group (group H ): Patients received midazolam & fentanyl continuous IV infusion and after 24h of mechanical ventilation, daily stopping of midazolam &fentanyl infusion & will be restarted by 1/2 of previous dose after patient shows signs of awaking. 3) Dexmedetomidine group (group D): With start of weaning from mechanical ventilation midazolam & fentanyl were stopped & dexmedetomidine was started by loading dose of 1μg/Kg IV over 20 minutes followed by continuous IV infusion of (0.5-0.7μg/Kg/h) till extubation. 4) Ketamine group (group K): With start of weaning from mechanical ventilation midazolam & fentanyl were stopped & ketamine was started by loading dose of 0.5mg/Kg IV followed by continuous IV infusion of (0.1-0.5 mg/Kg/h) till extubation. Following parameters recorded: -Total dose of midazolam & fentanyl used in each group. - Duration of mechanical ventilation & duration of ICU stay. - Time from start of weaning till extubation. -The need for supplementary bolus doses of sedatives & analgesics (eg. fentanyl , midazolam or dexmedetomidine as clinically indicated). -Adverse effects (eg. self extubation, hemodynamic instability, failed weaning & need for re-intubation). - Changes in heart rate (HR), mean arterial pressure (MAP) and respiratory rate (RR ) (Immediately before start of weaning, 1h and 2h after start of weaning, before extubation and post-extubation). Results: Duration of mechanical ventilation, duration of ICU stay and total dose of fentanyl & midazolam requirement showed significant decrease (P= 0.0001, 0.0005, 0.0012, 0.0002 respectively) in group D (3.18±0.37days, 4.01±0.5 days, 2.14±0.51 mg & 2.65±0.72 gm respectively) in comparison with the group C (6.14±0.82 days, 8.1±0.76 days, 4.42±0.72 mg & 4.3±0.69 gm respectively), group H (4.34±0.91 days, 5.4±1.04 days, 3.11±0.84 mg & 3.25±0.66 gm respectively) & group K (4.41±0.93 days, 5.1±0.8 days, 3.01± 0.4 mg & 3.19± 0.54 gm respectively). Also, they showed significant decrease in group K & group H in comparison with group C. Time from start of weaning till extubation showed significant decrease (P= 0.0002) in group K (8.6±2.1 h), group D (5.7±1.5 h) & group H (9.4±1.9 h) in comparison with group C (12.3±2.2 h). Group D showed the shortest time between start of weaning till extubation in comparison with the other three groups. Group D showed significant decrease in HR & MAP (P<0.05) in comparison with group C, group H &group K. While group K showed insignificant increase in HR & MAP (P>0.05) in comparison with group C. Respiratory rate showed significant decrease (P<0.05) in group H, group K & group D in comparison with group C. Conclusion: Although the strategy of sedation –analgesia holiday was effective in reducing both cumulative and withdrawal symptoms of midazolam & fentanyl, it showed less beneficial effect in comparison with dexmedetomidine. In our study the strategy of using dexmedetomidine during weaning was the best as it does not only control withdrawal symptoms but also had hemodynamic stability without respiratory depression resulting into early weaning, shorter time of mechanical ventilation and length of ICU stay. As regard ketamine, its hemodynamic effect hinders its use as sole sedative agent and need to be combined with other drugs.

ICID 903260